Clinical Course After a Single Cycle of Rozanolixizumab in Generalized Late-Onset Myasthenia Gravis. [PDF]
Aritake S, Nagai A.
europepmc +1 more source
A Functional Investigation of Antibody Fc-FcRn Variant Binding Guided by In Silico Free Energy Perturbation Methods. [PDF]
Sampson JM +11 more
europepmc +1 more source
Systemic Inflammation as a Modulator of FcRn-dependent IgG Pharmacokinetics: Implications for Broadly Neutralising Antibody Efficacy in HIV Prevention. [PDF]
Khumalo A +4 more
europepmc +1 more source
Comparative Characterisation of Five Plasma-Derived Human Serum Albumin Preparations: Structural Integrity, Functional Properties, and Quality Attributes. [PDF]
Farhane Z +6 more
europepmc +1 more source
Comparative efficacy, safety, and functional recovery of neonatal fc receptor inhibitors and conventional immunotherapies for chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review and network meta-analysis. [PDF]
Jiang Q, Gu Z.
europepmc +1 more source
Research Progress in Pharmacological Targeted Therapy for Myasthenia Gravis. [PDF]
Zhou Y, Wu Y, Meng Z.
europepmc +1 more source
Particles of echovirus 18 open to release their genomes in vivo. [PDF]
Mukhamedova L +13 more
europepmc +1 more source
Age and Treatment Efficacy in Myasthenia Gravis: A Systematic Review, Meta-Analysis, and Meta-Regression. [PDF]
Nelke C +4 more
europepmc +1 more source
Human Antibody Isotypes, Subclasses, Allotypes and Fc Biology: Clinical Implications in Infectious Diseases, Autoimmunity, and Cancer. [PDF]
Gautam S +4 more
europepmc +1 more source
Immune Mechanisms Underlying Neonatal Protection Following Maternal RSV Vaccination. [PDF]
Nikolaou AI +5 more
europepmc +1 more source

